These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25143260)
1. Collapse of the native structure caused by a single amino acid exchange in human NAD(P)H:quinone oxidoreductase(1.). Lienhart WD; Gudipati V; Uhl MK; Binter A; Pulido SA; Saf R; Zangger K; Gruber K; Macheroux P FEBS J; 2014 Oct; 281(20):4691-4704. PubMed ID: 25143260 [TBL] [Abstract][Full Text] [Related]
2. Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1). Lienhart WD; Strandback E; Gudipati V; Koch K; Binter A; Uhl MK; Rantasa DM; Bourgeois B; Madl T; Zangger K; Gruber K; Macheroux P FEBS J; 2017 Apr; 284(8):1233-1245. PubMed ID: 28236663 [TBL] [Abstract][Full Text] [Related]
3. A small molecule chaperone rescues the stability and activity of a cancer-associated variant of NAD(P)H:quinone oxidoreductase 1 in vitro. Strandback E; Lienhart WD; Hromic-Jahjefendic A; Bourgeois B; Högler A; Waltenstorfer D; Winkler A; Zangger K; Madl T; Gruber K; Macheroux P FEBS Lett; 2020 Feb; 594(3):424-438. PubMed ID: 31605637 [TBL] [Abstract][Full Text] [Related]
4. Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands. Medina-Carmona E; Palomino-Morales RJ; Fuchs JE; Padín-Gonzalez E; Mesa-Torres N; Salido E; Timson DJ; Pey AL Sci Rep; 2016 Feb; 6():20331. PubMed ID: 26838129 [TBL] [Abstract][Full Text] [Related]
5. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548 [TBL] [Abstract][Full Text] [Related]
6. NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places. Pey AL; Megarity CF; Timson DJ Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30518535 [TBL] [Abstract][Full Text] [Related]
7. NQO1: A target for the treatment of cancer and neurological diseases, and a model to understand loss of function disease mechanisms. Beaver SK; Mesa-Torres N; Pey AL; Timson DJ Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):663-676. PubMed ID: 31091472 [TBL] [Abstract][Full Text] [Related]
8. Thermodynamics of cooperative binding of FAD to human NQO1: Implications to understanding cofactor-dependent function and stability of the flavoproteome. Clavería-Gimeno R; Velazquez-Campoy A; Pey AL Arch Biochem Biophys; 2017 Dec; 636():17-27. PubMed ID: 29100982 [TBL] [Abstract][Full Text] [Related]
9. A mechanism for cancer-associated inactivation of NQO1 due to P187S and its reactivation by the consensus mutation H80R. Muñoz IG; Morel B; Medina-Carmona E; Pey AL FEBS Lett; 2017 Sep; 591(18):2826-2835. PubMed ID: 28771686 [TBL] [Abstract][Full Text] [Related]
10. Cancer-associated variants of human NQO1: impacts on inhibitor binding and cooperativity. Megarity CF; Timson DJ Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31431515 [TBL] [Abstract][Full Text] [Related]
11. Site-to-site interdomain communication may mediate different loss-of-function mechanisms in a cancer-associated NQO1 polymorphism. Medina-Carmona E; Neira JL; Salido E; Fuchs JE; Palomino-Morales R; Timson DJ; Pey AL Sci Rep; 2017 Mar; 7():44532. PubMed ID: 28291250 [TBL] [Abstract][Full Text] [Related]
12. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians. Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831 [TBL] [Abstract][Full Text] [Related]
13. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects. Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623 [TBL] [Abstract][Full Text] [Related]
14. Anion-specific interaction with human NQO1 inhibits flavin binding. Pey AL Int J Biol Macromol; 2019 Apr; 126():1223-1233. PubMed ID: 30615965 [TBL] [Abstract][Full Text] [Related]
15. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Nebert DW; Roe AL; Vandale SE; Bingham E; Oakley GG Genet Med; 2002; 4(2):62-70. PubMed ID: 11882782 [TBL] [Abstract][Full Text] [Related]
16. FAD-deficient P187S mutation of NAD(P)H:quinone oxidoreductase 1 (NQO1*2) binds and accelerates β-amyloid aggregation. Panja S; Siegel D; Camandola S; de Cabo R; Ross D; Mallela KMG Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281795 [TBL] [Abstract][Full Text] [Related]
17. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells. Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038 [TBL] [Abstract][Full Text] [Related]
19. NQO1 rs1800566 polymorph is more prone to NOx induced lung injury: Endorsing deleterious functionality through informatics approach. Basharat Z; Messaoudi A; Ruba S; Yasmin A Gene; 2016 Oct; 591(1):14-20. PubMed ID: 27349566 [TBL] [Abstract][Full Text] [Related]
20. A Dynamic Core in Human NQO1 Controls the Functional and Stability Effects of Ligand Binding and Their Communication across the Enzyme Dimer. Vankova P; Salido E; Timson DJ; Man P; Pey AL Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31726777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]